Rating History for PDL BioPharma (PDLI) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for PDLI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/22/2016 N/A New Coverage Overweight
(N/A)		 4.00
(N/A)		 2.08
(2.47)		 18.75% Details